By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301




Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.

Company News
Argos Therapeutics, Inc. (ARGS) Commits To New Headquarters In Durham 8/25/2014 7:29:16 AM
Argos Therapeutics, Inc. (ARGS) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/13/2014 4:00:01 PM
Argos Therapeutics, Inc. (ARGS) To Hold Second Quarter 2014 Financial Results Conference Call On Wednesday, August 13, 2014 8/6/2014 10:03:29 AM
Argos Therapeutics, Inc. (ARGS) Presents Data Showing The Impact Of HIV Antigen Sequence Divergence On Durable Viral Control Following Treatment With Autologous Immune Therapy 7/22/2014 10:41:31 AM
Argos Therapeutics, Inc. (ARGS) To Present At Two Upcoming Healthcare Conferences 6/11/2014 6:36:50 AM
Argos Therapeutics, Inc. (ARGS) To Host Post-American Society of Clinical Oncology Conference Call And Webcast, Monday, June 9, 2014 6/5/2014 9:25:13 AM
Argos Therapeutics, Inc. (ARGS) Release: Treatment With AGS-003 And Sunitinib Associated With Doubling Of Expected Survival In Patients With Unfavorable Risk Metastatic Renal Cell Carcinoma (mRCC) 6/2/2014 9:19:59 AM
Argos Therapeutics, Inc. (ARGS) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/28/2014 9:52:57 AM
Argos Therapeutics, Inc. (ARGS) Named As A Red Herring Top 100 North America Winner 5/27/2014 9:07:57 AM
Argos Therapeutics, Inc. (ARGS) CSO Dr. Charles Nicolette To Join Panel Discussion On Challenges In Clinical Trial Development At The Society Of Gene & Cell Therapy Annual Meeting 5/20/2014 9:45:24 AM